rivastigmine has been researched along with Ischemic Attack, Transient in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mizukawa, K; Mori, A; Ogawa, N; Tanaka, K | 1 |
Asanuma, M; Kondo, Y; Mizukawa, K; Mori, A; Nishibayashi, S; Ogawa, N; Tanaka, K | 1 |
Morimoto, T; Sakaki, T; Tominaga, M; Tsujimoto, S | 1 |
3 other study(ies) available for rivastigmine and Ischemic Attack, Transient
Article | Year |
---|---|
Post-ischemic administration of the acetylcholinesterase inhibitor ENA-713 prevents delayed neuronal death in the gerbil hippocampus.
Topics: Animals; Astrocytes; Carbamates; Cell Death; Cholinesterase Inhibitors; Gerbillinae; Glial Fibrillary Acidic Protein; Hippocampus; Hypertrophy; Ischemic Attack, Transient; Neurons; Phenylcarbamates; Pyramidal Cells; Rivastigmine | 1995 |
Acetylcholinesterase inhibitor ENA-713 protects against ischemia-induced decrease in pre- and postsynaptic cholinergic indices in the gerbil brain following transient ischemia.
Topics: Acetylcholine; Animals; Carbamates; Cholinesterase Inhibitors; Gerbillinae; Ischemic Attack, Transient; Molecular Structure; Phenylcarbamates; Receptors, Muscarinic; Rivastigmine; Synapses | 1994 |
The effect of acetylcholinesterase inhibitor (SDZ ENA 713) for r-CBF and focal cerebral ischaemia.
Topics: Acetylcholine; Animals; Brain; Brain Ischemia; Carbamates; Cats; Cerebral Infarction; Cholinesterase Inhibitors; Female; Ischemic Attack, Transient; Laser-Doppler Flowmetry; Male; Phenylcarbamates; Pia Mater; Regional Blood Flow; Rivastigmine; Vascular Resistance | 1993 |